Wedbush analyst David Chiaverini downgrades Silvergate Capital (NYSE:SI) from Neutral to Underperform and announces $4 price target.
Meridian Bioscience Launches Lyo-Ready qPCR Saliva-Specific Master Mixes For DNA & RNA Direct Detection
Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of two new master mixes that detect DNA and RNA in crude